Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.
暂无分享,去创建一个
Kishore Guda | Charles Giardina | P. Nambiar | C. Giardina | D. Rosenberg | K. Guda | R. Raja | Rajiv Raja | Prashant R Nambiar | Daniel W Rosenberg | Wataru Aizu | Wataru Aizu
[1] M. Serrano,et al. The INK4a/ARF locus in murine tumorigenesis. , 2000, Carcinogenesis.
[2] A. Papanikolaou,et al. Azoxymethane induces KI‐ras activation in the tumor resistant AKR/J mouse colon , 2000, Molecular carcinogenesis.
[3] W. Bodmer,et al. p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[4] F. Zindy,et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.
[5] R H Whitehead,et al. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Gallinger,et al. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. , 1993, Carcinogenesis.
[7] Richard A. Ashmun,et al. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.
[8] Q. S. Wang,et al. Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis. , 1998, Carcinogenesis.
[9] N. Wake,et al. Alterations of the p16INK4A gene in human ovarian cancers , 1997, Molecular carcinogenesis.
[10] F. Zindy,et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] Karen H. Vousden,et al. p14ARF links the tumour suppressors RB and p53 , 1998, Nature.
[12] G. Kelloff,et al. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. , 1994, Carcinogenesis.
[13] L. Yin,et al. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. , 2000, Gastroenterology.
[14] R. DePinho,et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.
[15] Q. S. Wang,et al. Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. , 1998, Cancer letters.
[16] Y. Xiong,et al. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. , 1999, Molecular cell.
[17] C. Sherr,et al. Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.
[18] M. Serrano,et al. p19ARF links the tumour suppressor p53 to Ras , 1998, Nature.
[19] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[20] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[21] P. Nambiar,et al. Mutational analysis of tumor suppressor gene p53 in feline vaccine site-associated sarcomas. , 2000, American journal of veterinary research.
[22] D. Ahnen,et al. AOM-induced mouse colon tumors do not express full-length APC protein. , 1997, Carcinogenesis.
[23] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[24] L. Chin,et al. Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.
[25] Channing S. Mahatan,et al. The Gut-enriched Krüppel-like Factor (Krüppel-like Factor 4) Mediates the Transactivating Effect of p53 on the p21 WAF1/Cip1 Promoter* , 2000, The Journal of Biological Chemistry.
[26] Taylor Murray,et al. Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.
[27] B. Trump,et al. Colon epithelium. II. In vivo studies of colon carcinogenesis. Light microscopic, histochemical, and ultrastructural studies of histogenesis of azoxymethane-induced colon carcinomas in Fischer 344 rats. , 1981, Journal of the National Cancer Institute.
[28] M. Serrano. The tumor suppressor protein p16INK4a. , 1997, Experimental cell research.
[29] G. Peters,et al. The p16INK4a/CDKN2A tumor suppressor and its relatives. , 1998, Biochimica et biophysica acta.
[30] E. Appella,et al. p53 transcriptional activity is essential for p53‐dependent apoptosis following DNA damage , 2000, The EMBO journal.
[31] L. Hartwell,et al. Cell cycle control and cancer. , 1994, Science.
[32] F. Zindy,et al. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. , 1999, Cancer research.
[33] A. Levine,et al. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. , 1999, Genes & development.
[34] S. Lowe,et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.
[35] Y. Xiong,et al. Control of p53 ubiquitination and nuclear export by MDM2 and ARF. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[36] P. Nambiar,et al. Differential Expression of p16INK4a in Azoxymethane‐Induced Mouse Colon Tumorigenesis , 2000, Molecular carcinogenesis.
[37] C. Harris,et al. Distinct pattern of p53 phosphorylation in human tumors , 2001, Oncogene.
[38] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[39] Ken Chen,et al. The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.
[40] Marc J. van de Vijver,et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers , 2000, Nature Genetics.
[41] J L Cleveland,et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.
[42] C. Fenoglio-Preiser,et al. Review Article: Aberrant Crypt Foci: A Review , 1999 .
[43] J. Bartek,et al. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. , 1990, Oncogene.
[44] S. Lowe,et al. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. , 2000, Genes & development.
[45] Q. S. Wang,et al. Transcription factor NF-kappaB participates in regulation of epithelial cell turnover in the colon. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[46] C. Fenoglio-Preiser,et al. Aberrant crypt foci: A review. , 1999, Toxicologic pathology.
[47] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[48] M. Krönke,et al. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “Acidic” sphingomyelin breakdown , 1992, Cell.
[49] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[50] D. Lane,et al. Regulation of the specific DNA binding function of p53 , 1992, Cell.
[51] L. Kedes,et al. Twist is a potential oncogene that inhibits apoptosis. , 1999, Genes & development.
[52] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[53] Kevin Ryan,et al. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 , 1998, The EMBO journal.
[54] S. Lowe,et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.
[55] W. El-Deiry,et al. Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[56] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[57] Q. S. Wang,et al. Quantitative assessment of azoxymethane-induced aberrant crypt foci in inbred mice. , 1999, Experimental and molecular pathology.